Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · IEX Real-Time Price · USD
12.09
-0.08 (-0.66%)
Jul 2, 2024, 4:30 PM EDT - Market closed
Mineralys Therapeutics Market Cap
Mineralys Therapeutics has a market cap or net worth of $600.25 million as of July 2, 2024. Its market cap has decreased by -3.98% in one year.
Market Cap
600.25M
Enterprise Value
261.69M
1-Year Change
-3.98%
Ranking
Category
Stock Price
$12.09
Market Cap Chart
Since the IPO on February 10, 2023, Mineralys Therapeutics's market cap has decreased from $624.91M to $600.25M, a decrease of -3.95%. That is a compound annual growth rate of -2.85%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 2, 2024 | 600.30M | 69.82% |
Dec 29, 2023 | 353.50M | -43.43% |
Feb 10, 2023 | 624.91M | - |
View and export this data all the way back to 2023.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Surmodics | 599.49M |
PureTech Health | 598.30M |
Cassava Sciences | 592.51M |
Fulgent Genetics | 587.11M |
Arbutus Biopharma | 583.14M |
REGENXBIO | 576.30M |
Celcuity | 574.96M |
Humacyte | 571.60M |